Trial
NCT04668209
Silmitasertib (CX-4945) in Patients With Severe Coronavirus Disease 2019 (COVID-19)
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Arizona
Collaborators
Senhwa Biosciences, Inc.
Condition
Coronavirus
Intervention
Silmitasertib
Why stopped
After 15 months of active enrollment and a lack of qualifying hospitalized COVID-19 patients, the Sponsor-Investigator, Marilyn Csete Glassberg, MD, decided to terminate recruitment before meeting the stated enrollment objectives.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-11-07